Matteo Bassetti
Researcher Next ID · RN-034993
Researcher · Biochemistry, Genetics and Molecular Biology
Terni, Italy
- Works count
- 1,026
- Citation count
- 53,003
- H-index
- 113
- i10-index
- 582
Research interests
Publications
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases · 2025 · https://doi.org/10.1016/s1473-3099(24)00749-7
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
Intensive Care Medicine · 2023 · https://doi.org/10.1007/s00134-022-06944-2
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
The Lancet Infectious Diseases · 2023 · https://doi.org/10.1016/s1473-3099(22)00872-6
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Intensive Care Medicine · 2023 · https://doi.org/10.1007/s00134-023-07033-8
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Nature Medicine · 2021 · 10.1038/s41591-021-01499-z
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study
Clinical Infectious Diseases · 2021 · https://doi.org/10.1093/cid/ciab176
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
The Lancet Infectious Diseases · 2021 · https://doi.org/10.1016/s1473-3099(20)30784-2
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
Clinical Microbiology and Infection · 2021 · 10.1016/j.cmi.2021.11.025
EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group
Clinical Infectious Diseases · 2021 · https://doi.org/10.1093/cid/ciaa1751
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey
Journal of Critical Care · 2020 · https://doi.org/10.1016/j.jcrc.2020.06.005
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
Intensive Care Medicine · 2020 · https://doi.org/10.1007/s00134-020-06091-6
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
The Lancet Infectious Diseases · 2020 · https://doi.org/10.1016/s1473-3099(20)30847-1
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Intensive Care Medicine · 2020 · https://doi.org/10.1007/s00134-020-06050-1
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
The Lancet Infectious Diseases · 2020 · 10.1016/s1473-3099(20)30796-9
Bloodstream infections in critically ill patients: an expert statement
Intensive Care Medicine · 2020 · 10.1007/s00134-020-05950-6
The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm
European Journal of Clinical Investigation · 2020 · 10.1111/eci.13209
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Clinical Infectious Diseases · 2019 · https://doi.org/10.1093/cid/ciz1008
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients
Intensive Care Medicine · 2019 · https://doi.org/10.1007/s00134-019-05599-w
Treatment of Infections Due to MDR Gram-Negative Bacteria
Frontiers in Medicine · 2019 · 10.3389/fmed.2019.00074
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused byKlebsiella pneumoniaeCarbapenemase–producingK. pneumoniae
Clinical Infectious Diseases · 2018 · 10.1093/cid/ciy492
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
JAMA · 2018 · 10.1001/jama.2018.12163
How to manage Pseudomonas aeruginosa infections
Drugs in Context · 2018 · 10.7573/dic.212527
2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections
World Journal of Emergency Surgery · 2018 · https://doi.org/10.1186/s13017-018-0219-9
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Infectious Diseases and Therapy · 2018 · https://doi.org/10.1007/s40121-018-0214-1
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
World Journal of Emergency Surgery · 2016 · https://doi.org/10.1186/s13017-016-0089-y
Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study
Journal of Antimicrobial Chemotherapy · 2015 · 10.1093/jac/dkv086
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
The Lancet Respiratory Medicine · 2014 · https://doi.org/10.1016/s2213-2600(14)70041-4
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts
Intensive Care Medicine · 2013 · https://doi.org/10.1007/s00134-013-3109-3
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Clinical Infectious Diseases · 2013 · 10.1093/cid/cit253
New antibiotics for bad bugs: where are we?
Annals of Clinical Microbiology and Antimicrobials · 2013 · 10.1186/1476-0711-12-22
ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures
Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12038
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Clinical Infectious Diseases · 2012 · https://doi.org/10.1093/cid/cis588
ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12040
ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12041
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12039
Current projects
No projects listed.